IP Verse

Crystalline Form Ii Of Anagrelide Hydrochloride Monohydrate - EP2945948

The patent EP2945948 was granted to Synthon on Apr 29, 2020. The application was originally filed on Jan 16, 2014 under application number EP14700674A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2945948

SYNTHON
Application Number
EP14700674A
Filing Date
Jan 16, 2014
Status
Opposition Rejected
Oct 21, 2022
Grant Date
Apr 29, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELKINGTON AND FIFEJan 29, 2021ELKINGTON AND FIFEWITHDRAWN

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS3932407
INTERNATIONAL-SEARCH-REPORTUS4146718
INTERNATIONAL-SEARCH-REPORTUS5391737
INTERNATIONAL-SEARCH-REPORTWO2009087673
OPPOSITIONUS3932407
OPPOSITIONUS4146718
OPPOSITIONUS5391737
OPPOSITIONWO2009087673

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- Igor Ivanisevic ET AL, "Uses of X-Ray Powder Diffraction In the Pharmaceutical Industry", Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing, doi:10.1002/9780470571224.pse414, (20100625), pages 1 - 42, URL: http://onlinelibrary.wiley.com/store/10.1002/9780470571224.pse414/asset/pse414.pdf?v=1&t=gsssyq3r&s=316303db60793cc15e15c87a2d3b6ec61b51414e, (20110920), XP055007590
OPPOSITION- Alfonso Gennaro, "molecular structure properties and states of matter ", The Science and Practice of Pharmacy, (19850101), page 185, The Science and Practice of Pharmacy, (20180123), XP055443314-
OPPOSITION- Anonymous, "Assessment report EMA/63484/2018", EMA, (20171214), EMA, (20221115), XP055981305-
OPPOSITION- Anonymous, "DATASHEET FOR THE DECISION T 0041/17", BOARDS OF APPEAL OF THE EUROPEAN PATENT OFFICE, (20200114), XP055981368-
OPPOSITION- Anonymous, "datasheet for the decision T 0777/08", CHAMBRE DE RECOURS DE L'OFFICE EUROPEEN DES BREVETS, (20110524), XP055981330-
OPPOSITION- "Approved Drug Products with Therapeutic Equivalence Evaluations", Orange Book-
OPPOSITION- Michael E.Aulton, "2. dissolution and solubility ", Pharmaceutics: The Science of Dosage Form Design, (20070101), pages 16,27,144 - 146, XP055981310-
OPPOSITION- Mike Bavin, "POLYMORPHISM IN PROCESS DEVELOPMENNT ", CHEMISTRY AND INDUSTRY , (19890821), pages 527 - 529, XP055981356-
OPPOSITION- Igor Ivanisevic, Richard B. Mcclurg, Paul J. Schields, "Uses of X-Ray Powder Diffraction In the Pharmaceutical Industry", Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing, John Wiley & Sons, Inc., doi:10.1002/9780470571224.pse414, pages 1 - 42, Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing, URL: http://onlinelibrary.wiley.com/store/10.1002/9780470571224.pse414/asset/pse414.pdf?v=1&t=gsssyq3r&s=316303db60793cc15e15c87a2d3b6ec61b51414e, (20110920), XP055007590
OPPOSITION- Alfons Grunenberg, "Polymorphie und Thermische Analyse pharmazeutischer Wirkstoffe", Pharmazie in unserer Zeit, (19970101), vol. 26, no. 5, doi:10.1002/pauz.19970260506, pages 224 - 231, XP055745450
OPPOSITION- D Singhal, "Drug polymorphism and dosage form design: a practical perspective", Advanced Drug Delivery Reviews, Elsevier, (20040223), vol. 56, no. 3, doi:10.1016/j.addr.2003.10.008, ISSN 0169409X, pages 335 - 347, XP055069199
OPPOSITION- BYRN S R et al., "Pharmaceutical solids: A Strategic Approach to Regulatory Considerations", Pharma Res, (19950000), vol. 12, no. 7, doi:10.1023/A:1016241927429, pages 945 - 954, XP055399407

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents